Pharmafile Logo
Pharmafocus logo
Advanced Search

GlobalData

Showing 15 posts of 15 posts found.

shutterstock_138095450

Ovarian cancer market set to smash $6.7 billion by 2025

October 28, 2019
Sales and Marketing Cancer, GlobalData, ovarian cancer, pharma

New research from GlobalData has forecast that the worldwide market for ovarian cancer is set to expand at a compound …

News
28246711066_52e38bc591_z

Healthcare industry could take up to five years to stabilise after no-deal Brexit

March 13, 2019
Manufacturing and Production, Medical Communications, Research and Development GlobalData, analysis, brexit, no-deal Brexit, surveys

The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to …

News
heart_money

Heart failure market to quadruple in ten years to $16 billion

July 6, 2017
Sales and Marketing GlobalData, Novartis, heart failure

New research from intelligence firm GlobalData has indicated that the market for heart failure drugs is forecast to expand by …

News
shutterstock_231613360

Non-small cell lung cancer market to hit $26bn by 2025

November 24, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer

New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …

News
flag_of_the_united_arab_emirates

UAE’s pharmaceutical market projected to grow from $3 billion to $5.7 billion by 2020

October 10, 2016
Manufacturing and Production Abu Dhabi, Dubai, GlobalData, United Arab Emires, growth, medical tourism, pharmaceutical market

United Arab Emirates’ pharmaceutical market is set for growth of 13% annually to reach $5.7 billion by 2020, up from …

News
shutterstock_76507048

Acute coronary syndrome market to grow to over $12 billion by 2022

August 15, 2016
Research and Development, Sales and Marketing GlobalData, acute coronary syndrome

The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …

News
eu

EU referendum outcome will have major consequences for UK’s pharma sector – GlobalData

June 23, 2016
Medical Communications, Sales and Marketing EMA, GlobalData, Pharma sector, brexit, referendum

The outcome of today’s referendum on the UK’s continuing membership of the European Union (EU) will have major consequences for …

News
dr_reddys_building

Indian pharma market set to grow to $55 billion by 2020

January 28, 2016
Sales and Marketing GlobalData

The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, …

News
clinical_trial-web

Pharma deals crucial to cutting R&D costs

December 16, 2015
Research and Development GlobalData, R&D, drug development, pharma, research and development

With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …

News
lung cancer x ray

Lung cancer market to hit $10.9bn by 2021

September 10, 2015
Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer

The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …

News
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015
Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …

News
Obama image

Pharma to profit from Obama reforms

March 18, 2015
Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance

President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …

News
AZ image

Pharma to lose $69 billion in five years as patents expire

December 12, 2014
Sales and Marketing AstraZeneca, GlobalData, Japanese firm Otsuka, Otsuka, lilly, pharma

Pharma companies are set to lose around $65 billion by 2019 due to drug patent expiries according to research firm …

News
nhs_sign

AML-related revenues to nearly triple by 2017

August 26, 2013
Medical Communications, Sales and Marketing GlobalData, acute myeloid leukaemia

News

Pharma R&D ‘untenable’

April 25, 2013
Research and Development, Sales and Marketing GlobalData, R&D

The current model by which pharma carries out R&D is ‘untenable’, according to a new report. But the research, from …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024